Anthera Pharmaceuticals

Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Thu, 09/8/16 - 09:50 am
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
In The Sea Of Biotechs, Anthera's Multi-Drug Pipeline Makes It Attractive
Yahoo/Benzinga
Thu, 09/17/15 - 05:20 pm
Anthera Pharmaceuticals
cystic fibrosis
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update
Yahoo/PR NewsWire
Sat, 11/15/14 - 09:32 am
Anthera Pharmaceuticals
earnings